# Blueberry Cognition Randomized Trial: What the Evidence Says
Canonical: https://www.migaku.app/guides/blueberry-cognition-randomized-trial-evidence-review
Category: evidence-review
Summary: Blueberry Cognition Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mi
Last reviewed: 2026-05-28
Reviewed by: Migaku Evidence Review
# Blueberry Cognition Randomized Trial: What the Evidence Says

## Quick Answer

Blueberry Cognition Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mixed biomedical and public-health sources, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 2 narrative review.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Polyphenol Composition, Antioxidant Properties, and Health Benefits of Moroccan-Cultivated Raspberries, Blackberries, and Blueberries: A Comprehensive Review | narrative review | 3 | 2026-04-13 | 10.3390/foods15081356 |
| Berry Consumption and Its Role in the Modulation of Obesity and Mild Cognitive Impairment | narrative review | 3 | 2026-02-19 | 10.3390/nu18040674 |

## What The Sources Report

- Berries are particularly rich in phenolic compounds, especially anthocyanins, which have been associated with antioxidant properties and may help reduce oxidative stress. [Alahyane Abderrahim (2026); evidence level 3]
- Recent genomic resources have expedited breeding of improved cultivars with enhanced traits including flavor, yield, and disease resistance. [Alahyane Abderrahim (2026); evidence level 3]
- Among these, the amnestic subtype, characterized predominantly by memory impairment, is particularly associated with an increased risk of progression to Alzheimer's disease dementia (AD). [dos Santos Gustavo Alves Andrade (2026); evidence level 3]
- The risk of progression is significantly higher in individuals diagnosed with MCI than in age-matched cognitively unimpaired populations. [dos Santos Gustavo Alves Andrade (2026); evidence level 3]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

For blueberry cognition randomized trial, the current source set is useful for orientation, but it is not yet broad enough for strong claims. Use cautious language and keep conclusions close to the cited sources.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Alahyane Abderrahim (2026). Polyphenol Composition, Antioxidant Properties, and Health Benefits of Moroccan-Cultivated Raspberries, Blackberries, and Blueberries: A Comprehensive Review. DOI: 10.3390/foods15081356. PMCID: PMC13115493. PMID: 42073244. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13115493/
- dos Santos Gustavo Alves Andrade (2026). Berry Consumption and Its Role in the Modulation of Obesity and Mild Cognitive Impairment. DOI: 10.3390/nu18040674. PMCID: PMC12943443. PMID: 41754191. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12943443/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.